Shares of Cadence Pharmaceuticals CADX are higher on the session by 1.85%, trading at $9.37.
Overall put volume is now running at 25.01x the daily average, with 4% of all puts traded being purchases on the offer. 5,678 contracts have traded on the session so far.
Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing product candidates for use in the hospital setting.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in